Lupin Limited has announced the appointment of Mr. Akhil Gupta as an Additional Director (Non-Executive, Independent) to its Board. This appointment is effective November 03, 2026, for a term of five consecutive years, concluding on November 02, 2031. Mr. Gupta brings over four decades of professional experience in finance and corporate strategy, including significant roles at Bharti Enterprises.
Board Strengthened with Experienced Director
Lupin Limited, a global pharmaceutical company, has announced a significant addition to its leadership team. Mr. Akhil Gupta has been appointed as an Additional Director (Non-Executive, Independent) to the company’s Board of Directors. This strategic appointment was unanimously approved by the Board following a recommendation from the Nomination and Remuneration Committee.
Key Details of the Appointment
- Effective Date: November 03, 2026
- Term: Five consecutive years, concluding on November 02, 2031.
- Role: Additional Director (Non-Executive, Independent)
- Subject to: Approval of the Members of the Company.
Mr. Gupta’s Extensive Experience
Mr. Akhil Gupta is a qualified Chartered Accountant with a distinguished career spanning over four decades. He has held pivotal roles in corporate strategy, finance, and governance. Notably, he served as the Vice Chairman of Bharti Enterprises Limited, contributing significantly to its growth. His experience also includes serving as the Non-Executive Independent Chairman of multiple prominent companies, including 360 ONE WAM Limited, Coforge Limited, and Valuedrive Technologies Limited.
His expertise extends to advising companies across various sectors such as infrastructure, renewable energy, automobiles, and tourism. Mr. Gupta is also recognized for his numerous prestigious accolades, including the EY Entrepreneur of the Year Award (Entrepreneur CEO) and multiple CNBC-TV18 Best CFO Awards.
Commitment to Governance and Growth
The company confirmed that Mr. Akhil Gupta is not debarred from holding the office of Director by any order passed by SEBI or any other authority. His appointment underscores Lupin’s commitment to robust corporate governance and leveraging experienced leadership to drive future growth. The Board meeting where this appointment was approved commenced on November 03, 2026, and concluded on November 04, 2026.
Source: BSE
